vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Veralto (VLTO). Click either name above to swap in a different company.

Veralto is the larger business by last-quarter revenue ($1.4B vs $1.0B, roughly 1.4× Alignment Healthcare, Inc.). Veralto runs the higher net margin — 17.9% vs -1.1%, a 18.9% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 6.8%). Veralto produced more free cash flow last quarter ($170.0M vs $-55.4M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 6.8%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Veralto Corporation is an American technology company headquartered in Waltham, Massachusetts. It produces products related to water analytics, water treatment, marking and coding, and packaging and color.

ALHC vs VLTO — Head-to-Head

Bigger by revenue
VLTO
VLTO
1.4× larger
VLTO
$1.4B
$1.0B
ALHC
Growing faster (revenue YoY)
ALHC
ALHC
+37.7% gap
ALHC
44.4%
6.8%
VLTO
Higher net margin
VLTO
VLTO
18.9% more per $
VLTO
17.9%
-1.1%
ALHC
More free cash flow
VLTO
VLTO
$225.4M more FCF
VLTO
$170.0M
$-55.4M
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
6.8%
VLTO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALHC
ALHC
VLTO
VLTO
Revenue
$1.0B
$1.4B
Net Profit
$-11.0M
$254.0M
Gross Margin
60.1%
Operating Margin
-1.0%
23.8%
Net Margin
-1.1%
17.9%
Revenue YoY
44.4%
6.8%
Net Profit YoY
64.6%
12.9%
EPS (diluted)
$-0.04
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
VLTO
VLTO
Q1 26
$1.4B
Q4 25
$1.0B
$1.4B
Q3 25
$993.7M
$1.4B
Q2 25
$1.0B
$1.3B
Q1 25
$926.9M
Q4 24
$701.2M
$1.3B
Q3 24
$692.4M
$1.3B
Q2 24
$681.3M
$1.3B
Net Profit
ALHC
ALHC
VLTO
VLTO
Q1 26
$254.0M
Q4 25
$-11.0M
$239.0M
Q3 25
$3.7M
$222.0M
Q2 25
$15.7M
$225.0M
Q1 25
$-9.1M
Q4 24
$-31.1M
$227.0M
Q3 24
$-26.4M
$219.0M
Q2 24
$-24.0M
$203.0M
Gross Margin
ALHC
ALHC
VLTO
VLTO
Q1 26
60.1%
Q4 25
60.1%
Q3 25
60.0%
Q2 25
60.4%
Q1 25
Q4 24
59.6%
Q3 24
59.6%
Q2 24
60.1%
Operating Margin
ALHC
ALHC
VLTO
VLTO
Q1 26
23.8%
Q4 25
-1.0%
23.2%
Q3 25
0.8%
22.8%
Q2 25
2.2%
24.2%
Q1 25
-0.6%
Q4 24
-3.2%
22.9%
Q3 24
-2.8%
23.4%
Q2 24
-2.7%
23.2%
Net Margin
ALHC
ALHC
VLTO
VLTO
Q1 26
17.9%
Q4 25
-1.1%
17.0%
Q3 25
0.4%
16.2%
Q2 25
1.5%
16.9%
Q1 25
-1.0%
Q4 24
-4.4%
16.9%
Q3 24
-3.8%
16.7%
Q2 24
-3.5%
15.8%
EPS (diluted)
ALHC
ALHC
VLTO
VLTO
Q1 26
$1.02
Q4 25
$-0.04
$0.95
Q3 25
$0.02
$0.89
Q2 25
$0.07
$0.90
Q1 25
$-0.05
Q4 24
$-0.15
$0.91
Q3 24
$-0.14
$0.88
Q2 24
$-0.13
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
VLTO
VLTO
Cash + ST InvestmentsLiquidity on hand
$604.2M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
Total Assets
$1.1B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
VLTO
VLTO
Q1 26
Q4 25
$604.2M
$1.8B
Q3 25
$644.1M
$1.6B
Q2 25
$503.8M
$1.2B
Q1 25
$479.5M
Q4 24
$470.6M
$1.1B
Q3 24
$381.0M
$1.3B
Q2 24
$363.7M
$1.0B
Total Debt
ALHC
ALHC
VLTO
VLTO
Q1 26
Q4 25
$323.2M
$2.7B
Q3 25
$322.7M
$2.7B
Q2 25
$322.3M
$2.6B
Q1 25
$321.9M
Q4 24
$321.4M
$2.6B
Q3 24
$212.0M
$2.6B
Q2 24
$211.7M
$2.6B
Stockholders' Equity
ALHC
ALHC
VLTO
VLTO
Q1 26
Q4 25
$179.3M
$2.8B
Q3 25
$161.9M
$2.7B
Q2 25
$141.0M
$2.3B
Q1 25
$108.1M
Q4 24
$99.9M
$2.0B
Q3 24
$114.5M
$2.0B
Q2 24
$123.7M
$1.7B
Total Assets
ALHC
ALHC
VLTO
VLTO
Q1 26
Q4 25
$1.1B
$7.4B
Q3 25
$1.1B
$7.2B
Q2 25
$1.0B
$6.6B
Q1 25
$895.6M
Q4 24
$782.1M
$6.4B
Q3 24
$692.3M
$6.3B
Q2 24
$716.3M
$5.9B
Debt / Equity
ALHC
ALHC
VLTO
VLTO
Q1 26
Q4 25
1.80×
0.94×
Q3 25
1.99×
1.01×
Q2 25
2.29×
1.14×
Q1 25
2.98×
Q4 24
3.22×
1.28×
Q3 24
1.85×
1.35×
Q2 24
1.71×
1.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
VLTO
VLTO
Operating Cash FlowLast quarter
$-50.4M
$182.0M
Free Cash FlowOCF − Capex
$-55.4M
$170.0M
FCF MarginFCF / Revenue
-5.5%
12.0%
Capex IntensityCapex / Revenue
0.5%
0.8%
Cash ConversionOCF / Net Profit
0.72×
TTM Free Cash FlowTrailing 4 quarters
$113.1M
$893.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
VLTO
VLTO
Q1 26
$182.0M
Q4 25
$-50.4M
$270.0M
Q3 25
$144.6M
$339.0M
Q2 25
$29.1M
$157.0M
Q1 25
$16.6M
Q4 24
$-8.7M
$285.0M
Q3 24
$26.2M
$224.0M
Q2 24
$23.5M
$251.0M
Free Cash Flow
ALHC
ALHC
VLTO
VLTO
Q1 26
$170.0M
Q4 25
$-55.4M
$258.0M
Q3 25
$139.1M
$323.0M
Q2 25
$21.1M
$142.0M
Q1 25
$8.4M
Q4 24
$-18.0M
$263.0M
Q3 24
$16.9M
$215.0M
Q2 24
$11.8M
$240.0M
FCF Margin
ALHC
ALHC
VLTO
VLTO
Q1 26
12.0%
Q4 25
-5.5%
18.4%
Q3 25
14.0%
23.6%
Q2 25
2.1%
10.7%
Q1 25
0.9%
Q4 24
-2.6%
19.6%
Q3 24
2.4%
16.4%
Q2 24
1.7%
18.6%
Capex Intensity
ALHC
ALHC
VLTO
VLTO
Q1 26
0.8%
Q4 25
0.5%
0.9%
Q3 25
0.6%
1.2%
Q2 25
0.8%
1.1%
Q1 25
0.9%
Q4 24
1.3%
1.6%
Q3 24
1.3%
0.7%
Q2 24
1.7%
0.9%
Cash Conversion
ALHC
ALHC
VLTO
VLTO
Q1 26
0.72×
Q4 25
1.13×
Q3 25
38.77×
1.53×
Q2 25
1.86×
0.70×
Q1 25
Q4 24
1.26×
Q3 24
1.02×
Q2 24
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons